InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hopfner Robert Lorne, Director. Director active across 3 companies, notably Rallybio Corp. Aggregated, 9 filings have been recorded. Split: 6 buys · 0 sell. Total volume traded: €7.1m. Activity tracked since 19 April 2022. The latest transaction was filed on 19 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hopfner Robert Lorne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,000 shares@ US$17.35100.0% of flowCommon StockSEC:0001012975-25-000937:0
Canonical exit: 19 Mar 2026 (T+90)
3,026 sharesCommon StockSEC:0001551966-25-000007:0
2,923,110 shares@ US$4.0058.3% of flowCommon StockSEC:0000950170-25-094089:0
119,048 shares@ US$4.807.3% of flowCommon StockSEC:0000950170-23-038268:0
Canonical exit: 30 Oct 2023 (T+90)
219,230 shares@ US$6.4818.3% of flowCommon StockSEC:0001209191-23-029521:0
Canonical exit: 9 Aug 2023 (T+90)
344,592 shares@ US$4.537920.3% of flowCommon StockSEC:0001209191-23-021647:0
Canonical exit: 27 Jun 2023 (T+90)
51,074 shares@ US$3.69522.5% of flowCommon StockSEC:0001209191-23-021559:0
Canonical exit: 25 Jun 2023 (T+90)
1,070,000 shares@ US$3.6921.5% of flowCommon StockSEC:0001209191-22-024919:0
Canonical exit: 18 Jul 2022 (T+90)
1,694,388 sharesCommon StockSEC:0000899243-21-031635:0
9 of 9 declarations
About Hopfner Robert Lorne
Hopfner Robert Lorne is Administrateur at Inozyme Pharma, Inc., Evommune, Inc. and Rallybio Corp. He has 9 filings in total, and across the 9 filings tracked, buys amount to EUR 7110175 with no reported sells, between 2021-08-04 and 2025-12-22. The most common transaction nature is Acquisition.
